清志寧益速通膠囊
清志寧益速通膠囊 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 1149036523
- Chinese name
- 清志寧益速通膠囊
- English name
- CINNAZULIN WESTON CAPSULES
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 萬寧生物科技股份有限公司
- Registration date
- 2025-06-13
- Published validity end
- 2030-06-13
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| DANDELION EXTRACT | DANDELION EXTRACT | Not identified |
| ALOE VERA LEAF EXTRACT | ALOE VERA LEAF EXTRACT | Not identified |
| REHMANNIA RADIX | REHMANNIA RADIX | Not identified |
| PHYLLOQUINONE | PHYLLOQUINONE | Vitamine K |
| POLLEN | POLLEN | Pollen |
| LECITHIN | LECITHIN | Not identified |
| FLAXSEED OIL | FLAXSEED OIL | Not identified |
| PROPOLIS | PROPOLIS | Propolis |
| CHOLECALCIFEROL | CHOLECALCIFEROL | Vitamine D |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE | Vitamine E |
| ASCORBIC ACID | ASCORBIC ACID | Vitamine C |
| MENAQUINONE | MENAQUINONE | Vitamine K |
| THIAMINE MONONITRATE | THIAMINE MONONITRATE | Vitamine B1 (thiamine) |
| PYRIDOXINE HCL | PYRIDOXINE HCL | Vitamine B6 |
| CYANOCOBALAMIN | CYANOCOBALAMIN | Vitamine B12 |
| NICOTINAMIDE | NICOTINAMIDE | Nicotinamide (vitamine B3) |
| CITRUS BIOFLAVONOIDS | CITRUS BIOFLAVONOIDS | Not identified |
| CHOLINE BITARTRATE | CHOLINE BITARTRATE | Not identified |
| INOSITOL | INOSITOL | Inositol |
| SOYBEAN OIL | SOYBEAN OIL | Not identified |
| BEESWAX | BEESWAX | Not identified |
| GELATIN | GELATIN | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| PURIFIED WATER | PURIFIED WATER | Not identified |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| BRILLIANT BLUE FCF | BRILLIANT BLUE FCF | Not identified |
| ALLURA RED AC | ALLURA RED AC | Not identified |
| TARTRAZINE | TARTRAZINE | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 清志寧益速通膠囊
- Active ingredients
- DANDELION EXTRACT;;ALOE VERA LEAF EXTRACT;;REHMANNIA RADIX;;PHYLLOQUINONE;;POLLEN;;LECITHIN;;FLAXSEED OIL;;PROPOLIS;;CHOLECALCIFEROL;;DL-ALPHA TOCOPHERYL ACETATE;;ASCORBIC ACID;;MENAQUINONE;;THIAMINE MONONITRATE;;PYRIDOXINE HCL;;CYANOCOBALAMIN;;NICOTINAMIDE;;CITRUS BIOFLAVONOIDS;;CHOLINE BITARTRATE;;INOSITOL;;SOYBEAN OIL;;BEESWAX;;GELATIN;;GLYCEROL;;PURIFIED WATER;;TITANIUM DIOXIDE;;BRILLIANT BLUE FCF;;ALLURA RED AC;;TARTRAZINE;;
- Valid until
- 1190613
- Registration number
- 1149036523
- Licence holder
- 萬寧生物科技股份有限公司
- Registration date
- 1140613
- Published reference
- DHC0B490365234
- Published English name
- CINNAZULIN WESTON CAPSULES
Official source
View the official register, number 1149036523
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- PROPOLIS
Read the warning, when it applies and the studies cited
PROPOLIS - Oral
Cautions and warnings
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are allergic to bee products, poplar tree products, or balsam of Peru (Brinker 2010; Marcucci 1995; Valsecchi and Cainelli 1984; Melli et al. 1983; Rudzki and Gryzwa 1983).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Relief of sore throat/mouth and throat infections.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (PPRC 2020; Scully 2006; Hsu et al. 2004; Teraki and Shiohara 2001; Machácková 1988; Hausen et al. 1987; Valsecchi and Cainelli 1984; Melli et al. 1983; Rudzki and Grzywa 1983).
9 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 30 May 2025
PROPOLIS Buccal
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are allergic to bee products, poplar tree products, or balsam of Peru (Brinker 2010; Marcucci 1995; Valsecchi and Cainelli 1984; Melli et al. 1983; Rudzki and Gryzwa 1983).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products, except those not swallowed (e.g., gargles, rinses).
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are pregnant or breastfeeding.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (PPRC 2020; Scully 2006; Hsu et al. 2004; Teraki and Shiohara 2001; Machácková 1988; Hausen et al. 1987; Valsecchi and Cainelli 1984; Melli et al. 1983; Rudzki and Grzywa 1983).
9 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- CHOLECALCIFEROL
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.